Trials of embryonic stem cells to launch in China
David had worked in Japan for several years before moving into journalism with Nature in 2000. His varied employment history includes translation for a semiconductor-manufacturing equipment company and teaching history to foreign exchange students. In addition to covering the Asian-Pacific region, David's interests encompass materials, Earth science and intellectual property.
Studies to treat vision loss and Parkinson's disease are the first to proceed under new regulations.